STOCK TITAN
  1. Home
  2. News
  3. DNA

Ginkgo Bioworks Holdings Inc - DNA STOCK NEWS

Welcome to our dedicated news page for Ginkgo Bioworks Holdings (Ticker: DNA), a resource for investors and traders seeking the latest updates and insights on Ginkgo Bioworks Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ginkgo Bioworks Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ginkgo Bioworks Holdings's position in the market.

News
Concentric by Ginkgo to Support CDC-Funded Consortium to Develop New AI-Based Technologies for Epidemic Forecasting
Rhea-AI Summary
Ginkgo Bioworks partners with Northeastern University to develop technologies for early warning and epidemic forecasting
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.49%
Tags
AI
-
News
Nosh.bio Leverages Ginkgo Strain Optimization Services to Enhance Meaty Taste of Mycoprotein
Rhea-AI Summary
German startup Nosh.bio partners with Ginkgo Bioworks to develop mycoprotein for animal-free food products. Nosh.bio aims to create a single-ingredient alternative to red meat that is healthier and tastes like real meat. Ginkgo's screening technology will help discover a superior strain of fungi for this purpose.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.52%
Tags
none
-
News
Concentric By Ginkgo and Texas A&M University Awarded USDA NIFA AFRI Grant to Conduct Genomic Animal Research to Prevent Zoonotic Disease Spillover
Rhea-AI Summary
Ginkgo Bioworks and Texas A&M University receive USDA grant to study SARS-CoV-2 in white-tailed deer populations in Texas, potentially impacting livestock and other animal species
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.23%
Tags
none
News
Ensovi Leverages Ginkgo Enzyme Services to Optimize Cell-Free Carbon Fixation Process for Biomanufacturing
Rhea-AI Summary
Ensovi Inc. partners with Ginkgo Bioworks to optimize its cell-free biomanufacturing platform for transforming CO2 into organic chemicals. The collaboration aims to reduce costs, expand product portfolio, and enable carbon-neutral manufacturing processes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.37%
Tags
none
-
News
Ginkgo Bioworks Announces Multi-Target RNA Discovery Collaboration with Pfizer
Rhea-AI Summary
Ginkgo Bioworks collaborates with Pfizer to discover RNA-based drug candidates, receiving an upfront payment and potential milestone payments up to $331 million. Ginkgo's RNA technology aims to create novel RNA constructs for more effective treatments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.89%
Tags
none
-
News
Ginkgo Bioworks and the Government of the Republic of Madagascar Announce Plans to Develop New Biosecurity Capabilities
Rhea-AI Summary
Ginkgo Bioworks and the Government of Madagascar have entered into an MOU to develop biosecurity capabilities in Madagascar, focusing on COVID-19 and other biological threats. Concentric by Ginkgo will provide infrastructure and tools to support Madagascar's public health institutions. Madagascar aims to implement a wastewater and nasal swab monitoring program at key ports of entry. This collaboration strengthens Concentric's international biosecurity network. The partners plan to expand biomonitoring capabilities across Africa. This initiative can help mitigate biological threats and support informed decision-making.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.26%
Tags
none
News
Factorial Biotechnologies and Ginkgo Bioworks Partner To Develop Enzyme for Single-Cell Library Prep Technology
Rhea-AI Summary
Factorial Biotechnologies and Ginkgo Bioworks announce a collaboration to develop a novel isothermal DNA polymerase for single-cell sequencing. Ginkgo Enzyme Services will provide the expertise under a success-based pricing model. Single-cell sequencing has been limited by complex workflows and high cost. Factorial aims to simplify the process with its extraction-free technology. The collaboration has the potential to impact scientific research in healthcare and life sciences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.15%
Tags
partnership
-
News
Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the World
Rhea-AI Summary
Ceres Nanosciences and Ginkgo Bioworks partner to bring pathogen monitoring capabilities to laboratories worldwide, enhancing biosecurity measures.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
partnership
-
News
Ginkgo Bioworks Announces Participation in Morgan Stanley 21st Annual Global Healthcare Conference
Rhea-AI Summary
Ginkgo Bioworks Holdings, Inc. announced that Anna Marie Wagner, Senior Vice President of Corporate Development, will participate in a fireside chat at the Morgan Stanley 21st Annual Global Healthcare Conference on September 13. The chat will be available for replay on the company's investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
News
Exacta Bioscience and Ginkgo Bioworks Announce Partnership to Optimize Exacta's Crop Protection Product
Rhea-AI Summary
Exacta Bioscience partners with Ginkgo Bioworks to enhance crop protection product FitoRoot, aiming for large-scale commercialization. FitoRoot is expected to expand to other Latin American markets, reducing cost of goods through fermentation and formulation optimization services. Positive impact on stock price expected.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4%
Tags
partnership
Stock DNA logo
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

#2015 Ranked by Market Cap
#4679 Ranked by Stock Gains
N/A Ranked by Dividends

DNA Stock Data

2.17B
1.12B
6.74%
83.82%
12.58%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States
Boston

About DNA

the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.